You do not have permission to access this chart.
Please Sign Up or Login

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson’s diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

44723

Address:

Novo Nordisk A/S Novo Allé Bagsvaerd 2880 Denmark

Website:

http://www.novonordisk.com

Phone:

45 44 44 88 88

Leave a comment

Your email address will not be published. Required fields are marked *